These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 18598106)

  • 1. Molecular profiling in the age of cancer genomics.
    Lin J; Li M
    Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of expression genomics for predicting treatment response in cancer.
    Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
    Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational prediction of cancer-gene function.
    Hu P; Bader G; Wigle DA; Emili A
    Nat Rev Cancer; 2007 Jan; 7(1):23-34. PubMed ID: 17167517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing takes centre stage in cancer profiling.
    Maher B
    Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
    Mitra AP; Lin H; Cote RJ; Datar RH
    Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oncoproteomics in the personalized management of cancer.
    Jain KK
    Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of expression profiling and proteomics in prostate cancer.
    Masters JR
    Anticancer Res; 2007; 27(3A):1273-6. PubMed ID: 17593619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy.
    Meyerson M; Carbone D
    J Clin Oncol; 2005 May; 23(14):3219-26. PubMed ID: 15886309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies for therapeutic design in molecular oncology using gene expression profiles.
    Ricci MS; el-Deiry WS
    Curr Opin Mol Ther; 2000 Dec; 2(6):682-90. PubMed ID: 11249746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches in cancer risk and response assessment.
    Petricoin EF; Liotta LA
    Trends Mol Med; 2004 Feb; 10(2):59-64. PubMed ID: 15102358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA microarrays: identification of gene signatures and their application in clinical practice.
    Magic Z; Radulovic S; Brankovic-Magic M
    J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genomics: promises and complexities.
    Zhang W; Labordé PM; Coombes KR; Berry DA; Hamilton SR
    Clin Cancer Res; 2001 Aug; 7(8):2159-67. PubMed ID: 11489789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primer: genomic and proteomic tools for the molecular dissection of disease.
    Walker EJ; Siminovitch KA
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systems approach to model metastatic progression.
    Taylor BS; Varambally S; Chinnaiyan AM
    Cancer Res; 2006 Jun; 66(11):5537-9. PubMed ID: 16740685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.